Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Kaoru Kondo"'
Publikováno v:
The Journal of the Japanese Association for Chest Surgery. 36:584-589
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a22071a8f9c79186628c3deebd34d969
https://doi.org/10.2995/jacsurg.36.584
https://doi.org/10.2995/jacsurg.36.584
Autor:
Kaoru Kondo, Kojiro Nagai, Hisato Shima, Narushi Yokota, Naoto Minagawa, Yasuhiko Koezuka, Go Ichien, Toshio Doi, Jun Minakuchi
Background A questionnaire related to patients’ physical condition is required to assess their quality of life and improve their self-management skills. Methods It was a descriptive, cross-sectional, multicenter study that aimed to assess the life-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::534ca4d4f1cdc92524eee2e5807c1eda
https://doi.org/10.21203/rs.3.rs-2610137/v1
https://doi.org/10.21203/rs.3.rs-2610137/v1
Autor:
Yelena Y Janjigian, Kohei Shitara, Markus Moehler, Marcelo Garrido, Pamela Salman, Lucjan Wyrwicz, Kensei Yamaguchi, Tomasz Skoczylas, Arinilda Campos Bragagnoli, Tianshu Liu, Michael Schenker, Patricio Yanez, Mustapha Tehfe, Ruben Kowalyszyn, Michalis V Karamouzis, Ricardo Bruges, Thomas Zander, Roberto Pazo-Cid, Erika Hitre, Kynan Feeney, James M Cleary, Valerie Poulart, Dana Cullen, Ming Lei, Hong Xiao, Kaoru Kondo, Mingshun Li, Jaffer A Ajani
Publikováno v:
Future Oncology.
What is this summary about? This is a summary of the 1-year results of a clinical research study known as CheckMate 649 published in The Lancet in June 2021. The 2-year results on the participants' health and overall quality of life from the same stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcb23f7960a24091d34af703f819c0cf
https://doi.org/10.2217/fon-2022-1149
https://doi.org/10.2217/fon-2022-1149
Autor:
Kohei Shitara, Jaffer A. Ajani, Markus Moehler, Marcelo Garrido, Carlos Gallardo, Lin Shen, Kensei Yamaguchi, Lucjan Wyrwicz, Tomasz Skoczylas, Arinilda Campos Bragagnoli, Tianshu Liu, Mustapha Tehfe, Elena Elimova, Ricardo Bruges, Thomas Zander, Sergio de Azevedo, Ruben Kowalyszyn, Roberto Pazo-Cid, Michael Schenker, James M. Cleary, Patricio Yanez, Kynan Feeney, Michalis V. Karamouzis, Valerie Poulart, Ming Lei, Hong Xiao, Kaoru Kondo, Mingshun Li, Yelena Y. Janjigian
Publikováno v:
Nature. 603:942-948
Standard first-line chemotherapy results in disease progression and death within one year in most patients with human epidermal growth factor receptor 2 (HER2)-negative gastro-oesophageal adenocarcinoma1–4. Nivolumab plus chemotherapy demonstrated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078a5e44f26db17857124296ce1764de
https://doi.org/10.1038/s41586-022-04508-4
https://doi.org/10.1038/s41586-022-04508-4
Publikováno v:
General Thoracic and Cardiovascular Surgery Cases. 1
Background Bronchial atresia is a congenital obstruction of the segmental or lobar bronchus that often leads to hyperinflation of the affected area. It can cause intractable infections and abnormal nodules in these regions and surgical resection need
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::104d3a102524caf6492d7f8c6d392723
https://doi.org/10.1186/s44215-022-00009-y
https://doi.org/10.1186/s44215-022-00009-y
Autor:
Kaoru Kondo, Kojiro Nagai, Hisato Shima, Narushi Yokota, Naoto Minagawa, Yasuhiko Koezuka, Go Ichien, Toshio Doi, Jun Minakuchi
Objective: A questionnaire suggestive of patients’ health status is needed to assess their quality of life and improve their self-management skills. It is a descriptive, cross-sectional and multicenter study. The aim of this study was to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee991ba3c9b82163faca554ca4396366
https://doi.org/10.21203/rs.3.rs-2098018/v2
https://doi.org/10.21203/rs.3.rs-2098018/v2
Autor:
Ricardo Bruges, Pamela Salman, Ruben Dario Kowalyszyn, M. Li, Lucjan Wyrwicz, Valerie Poulart, Michalis V. Karamouzis, Arinilda Silva Campos Bragagnoli, Roberto Pazo-Cid, Marcelo Garrido, Yelena Y. Janjigian, Tomasz Skoczylas, Lin Shen, Mustapha Tehfe, Kensei Yamaguchi, Ming Lei, Michael Schenker, Thomas Zander, H. Xiao, Erika Hitre, Kynan Feeney, Markus Moehler, Kaoru Kondo, Kohei Shitara, Patricio Eduardo Yanez, Tianshu Liu, Dana Cullen, James M. Cleary, Jaffer A. Ajani
Publikováno v:
The Lancet. 398:27-40
First-line chemotherapy for advanced or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or gastro-oesophageal junction adenocarcinoma has a median overall survival (OS) of less than 1 year. We aimed to evaluate first-line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb05d865e9dd523198c246e5a56a5429
https://doi.org/10.1016/s0140-6736(21)00797-2
https://doi.org/10.1016/s0140-6736(21)00797-2
Autor:
Yuichiro, Doki, Jaffer A, Ajani, Ken, Kato, Jianming, Xu, Lucjan, Wyrwicz, Satoru, Motoyama, Takashi, Ogata, Hisato, Kawakami, Chih-Hung, Hsu, Antoine, Adenis, Farid, El Hajbi, Maria, Di Bartolomeo, Maria I, Braghiroli, Eva, Holtved, Sandra A, Ostoich, Hye R, Kim, Masaki, Ueno, Wasat, Mansoor, Wen-Chi, Yang, Tianshu, Liu, John, Bridgewater, Tomoki, Makino, Ioannis, Xynos, Xuan, Liu, Ming, Lei, Kaoru, Kondo, Apurva, Patel, Joseph, Gricar, Ian, Chau, Yuko, Kitagawa, Rachna T, Shroff
Publikováno v:
Doki, Y, Ajani, J A, Kato, K, Xu, J, Wyrwicz, L, Motoyama, S, Ogata, T, Kawakami, H, Hsu, C H, Adenis, A, El Hajbi, F, Di Bartolomeo, M, Braghiroli, M I, Holtved, E, Ostoich, S A, Kim, H R, Ueno, M, Mansoor, W, Yang, W C, Liu, T, Bridgewater, J, Makino, T, Xynos, I, Liu, X, Lei, M, Kondo, K, Patel, A, Gricar, J, Chau, I, Kitagawa, Y & CheckMate 648 Trial Investigators 2022, ' Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma ', The New England Journal of Medicine, vol. 386, no. 5, pp. 449-462 . https://doi.org/10.1056/NEJMoa2111380
BACKGROUND: First-line chemotherapy for advanced esophageal squamous-cell carcinoma results in poor outcomes. The monoclonal antibody nivolumab has shown an overall survival benefit over chemotherapy in previously treated patients with advanced esoph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::756f60de0ad71943361b198f70779f11
https://pubmed.ncbi.nlm.nih.gov/35660032
https://pubmed.ncbi.nlm.nih.gov/35660032
Autor:
Markus Moehler, Guillermo Mendez, Kaoru Kondo, Astrid Lièvre, E. Van Cutsem, Cecile Grootscholten, K. Geboes, James M. Cleary, Ming Lei, Jaffer A. Ajani, Hope E. Uronis, Elena Elimova, S. Soleymani, Thomas Zander, Satoru Motoyama, Joshua Zhang, Guillaume Piessen, Josephine Feliciano, Jarosław Kużdżał, Ronan J. Kelly
Publikováno v:
Annals of Oncology. 32:S1045-S1046
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8b82aff7261c001704e2765ed10c63c
https://doi.org/10.1016/j.annonc.2021.08.1490
https://doi.org/10.1016/j.annonc.2021.08.1490